LDT Pill - white oval
Generic Name: telbivudine
Pill with imprint LDT is White, Oval and has been identified as Tyzeka 600 mg. It is supplied by Novartis Corporation.
Tyzeka is used in the treatment of Hepatitis B and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tyzeka 600 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LDT
Tyzeka
- Generic Name
- telbivudine
- Imprint
- LDT
- Strength
- 600 mg
- Color
- White
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Corporation
- National Drug Code (NDC)
- 00078-0538 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hypromelloses,
polyethylene glycol,
magnesium stearate,
microcrystalline cellulose,
povidone,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "LDT"
More about Tyzeka (telbivudine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
